| 000 | 01718 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518012333.0 | ||
| 264 | 0 | _c20190611 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1744-2818 | ||
| 024 | 7 |
_a10.1080/13506129.2018.1536043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRutten, Karlijn H G | |
| 245 | 0 | 0 |
_aHaematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016. _h[electronic resource] |
| 260 |
_bAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis _cDec 2018 |
||
| 300 |
_a227-233 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aBortezomib _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHematologic Tests |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Light-chain Amyloidosis _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aRaymakers, Reinier A P | |
| 700 | 1 | _aHazenberg, Bouke P C | |
| 700 | 1 | _aNienhuis, Hans L A | |
| 700 | 1 | _aVellenga, Edo | |
| 700 | 1 | _aMinnema, Monique C | |
| 773 | 0 |
_tAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis _gvol. 25 _gno. 4 _gp. 227-233 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/13506129.2018.1536043 _zAvailable from publisher's website |
| 999 |
_c29126920 _d29126920 |
||